According to the Zhitong Finance App, Xinghu Technology (600866.SH) issued an announcement. The company and its participating subsidiary Guangdong Guangxin Innovation Research Institute Co., Ltd. (“Guangxin Research Institute”) jointly funded the establishment of Guangxin Biotechnology Innovation (Shenzhen) Co., Ltd. (“Guangxin Research Institute”) in the early stages, and the company held 51% of the shares. Currently, the two parties plan to increase the capital of Guangxin Biotech in the same proportion in cash. The company will invest 61.2 million yuan, and Guangxin Research Institute will invest 5880.00 million yuan. The price of the capital increase is 1 yuan/registered capital. After the transaction was completed, the company still holds 51% of the shares in Guangzhou New Life.